Icon PLC
ICLR- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001060955
In the last 90 days, Icon PLC insiders filed 0 open-market purchases and 8 sales; 426 institutions reported holding it in 13F filings for Q2 2026, worth $13.9B in total; superinvestors Harris Associates (Oakmark) and Greenhaven Associates hold it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:17 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Revenue | $8.25B | $8.28B | $8.12B | $7.74B | $5.48B |
| Cost of revenue | – | $5.85B | $5.72B | $5.53B | $3.97B |
| Selling, general and administrative | $780.1M | $728.3M | $768.6M | $778.8M | $585.3M |
| Operating income | $442.8M | $1.10B | $956.2M | $795.2M | $378.5M |
| Interest expense | $188.1M | $206.2M | $336.7M | $229.7M | $182.4M |
| Income tax | $23.1M | $77.7M | $11.7M | $59.4M | $41.3M |
| Net income | $229.3M | $791.5M | $612.3M | $505.3M | $153.2M |
| EPS, basic | $2.92 | $9.60 | $7.46 | $6.20 | $2.28 |
| EPS, diluted | $2.90 | $9.53 | $7.40 | $6.13 | $2.25 |
| Weighted shares, basic | 78.4M | 82.5M | 82.1M | 81.5M | 67.1M |
| Weighted shares, diluted | 79.0M | 83.0M | 82.7M | 82.5M | 68.1M |
| Margins and growth | |||||
| Operating margin | 5.4% | 13.3% | 11.8% | 10.3% | 6.9% |
| Net margin | 2.8% | 9.6% | 7.5% | 6.5% | 2.8% |
| Revenue growth, year over year | −0.4% | +2.0% | +4.9% | +41.2% | +95.9% |
| Net income growth, year over year | −71.0% | +29.3% | +21.2% | +229.9% | −53.9% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Cash and equivalents | $647.3M | $538.8M | $378.1M | $288.8M | $752.2M |
| Accounts receivable | $1.47B | $1.40B | $1.79B | $1.73B | $1.34B |
| Inventory | – | – | – | – | $5.80M |
| Total current assets | $3.50B | $3.53B | $3.41B | $3.23B | $2.94B |
| Property, plant and equipment | $395.7M | $382.9M | $361.2M | $350.3M | $336.4M |
| Goodwill | $8.73B | $9.05B | $9.02B | $8.97B | $9.04B |
| Intangible assets | $3.25B | $3.56B | $3.86B | $4.28B | $4.71B |
| Total assets | $16.3B | $16.9B | $17.0B | $17.2B | $17.4B |
| Accounts payable | $192.1M | $173.0M | $131.6M | $81.2M | $90.8M |
| Total current liabilities | $3.20B | $2.80B | $2.83B | $2.69B | $2.48B |
| Long-term debt | $2.87B | $3.40B | $3.67B | $4.60B | $5.38B |
| Total liabilities | $7.08B | $7.35B | $7.75B | $8.69B | $9.32B |
| Shareholders' equity | $9.19B | $9.52B | $9.24B | $8.50B | $8.07B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Operating cash flow | $1.04B | $1.29B | $1.16B | $563.3M | $829.1M |
| Capital expenditures | $174.2M | $168.1M | $140.7M | $142.2M | $93.8M |
| Free cash flow | $862.0M | $1.12B | $1.02B | $421.2M | $735.4M |
| Depreciation and amortization | $383.0M | $488.5M | $586.0M | $569.5M | $315.0M |
| Stock-based compensation | $102.0M | $45.9M | $55.7M | $70.5M | $133.8M |
| Share buybacks | $750.0M | $500.0M | $0 | $100.0M | $0 |
| Investing cash flow | -$187.5M | -$266.8M | -$226.7M | -$145.9M | -$6.02B |
| Financing cash flow | -$771.3M | -$837.2M | -$844.0M | -$864.2M | $5.11B |
| Net change in cash | $108.5M | $160.7M | $89.3M | -$463.4M | -$88.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.2% | 0.6% | 0.7% | 0.9% | 2.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.